Poor outcomes in COVID‐19 correlate with clinical and laboratory features of cytokine storm
syndrome. Broad screening for cytokine storm and early, targeted antiinflammatory therapy …

BACKGROUND Initial reports from the severe acute respiratory coronavirus 2 (SARS–CoV-2)
pandemic described children as being less susceptible to coronavirus disease 2019 (…

Objective To develop criteria for the classification of macrophage activation syndrome (MAS)
in patients with systemic juvenile idiopathic arthritis (JIA). Methods A multistep process, …

Objective To provide guidance on the management of Multisystem Inflammatory Syndrome
in Children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …

Objective To provide guidance on the management of multisystem inflammatory syndrome
in children (MIS‐C), a condition characterized by fever, inflammation, and multiorgan …

… Edward M Behrens , Edward M Behrens … Kathleen Chiotos, Hamid Bassiri, Edward M
Behrens, Allison M Blatz, Joyce Chang, Caroline Diorio, Julie C Fitzgerald, Alexis Topjian …

OBJECTIVE: Macrophage activation syndrome (MAS) is a well described, but purportedly
uncommon manifestation of systemic juvenile idiopathic arthritis (SJIA). There is evidence to …

Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS)
are 2 similar diseases characterized by a cytokine storm, overwhelming inflammation, …

“Cytokine storm syndrome” is a diverse set of conditions unified by a clinical phenotype of
systemic inflammation, multi-organ failure, hyperferritinemia, and, if untreated, often death. …

Pediatric coronavirus disease 2019 (COVID-19) after SARS-CoV-2 infection is associated
with fewer hospitalizations and often milder disease than in adults. A subset of children, …